Agilon Health (NYSE:AGL) Shares Up 9.3% – Here’s What Happened

Shares of Agilon Health, Inc. (NYSE:AGL) traded up 9.3% during mid-day trading on Wednesday . The stock traded as high as $8.18 and last traded at $8.6440. 31,250 shares were traded during mid-day trading, a decline of 88% from the average session volume of 266,933 shares. The stock had previously closed at $7.91.

Analyst Ratings Changes

A number of equities analysts have commented on the company. BTIG Research restated a “neutral” rating on shares of Agilon Health in a research note on Friday, December 12th. Barclays cut their target price on Agilon Health from $25.00 to $12.50 and set an “underweight” rating for the company in a research report on Friday, February 27th. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, January 21st. Wells Fargo & Company boosted their price target on Agilon Health from $25.00 to $37.50 and gave the company an “overweight” rating in a research note on Friday, February 27th. Finally, Citigroup cut their price objective on shares of Agilon Health from $21.25 to $18.75 and set a “neutral” rating for the company in a research report on Tuesday, March 3rd. Three research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $51.93.

Agilon Health Stock Up 9.3%

The firm has a 50 day simple moving average of $13.97 and a two-hundred day simple moving average of $18.53. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $176.87 million, a P/E ratio of -0.45 and a beta of 0.33.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). Agilon Health had a negative net margin of 6.60% and a negative return on equity of 120.82%. The business had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.46 billion. On average, equities research analysts expect that Agilon Health, Inc. will post -0.59 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of AGL. Wealthcare Advisory Partners LLC acquired a new position in shares of Agilon Health during the third quarter worth $26,000. LPL Financial LLC boosted its holdings in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares in the last quarter. Krilogy Financial LLC bought a new stake in Agilon Health during the 4th quarter worth $34,000. CIBC Bancorp USA Inc. bought a new stake in Agilon Health during the 3rd quarter worth $34,000. Finally, Merit Financial Group LLC acquired a new position in Agilon Health in the 4th quarter worth about $35,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.